vindesine has been researched along with Diffuse Large B-Cell Lymphoma in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (18.75) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, W; Lei, W; Pan, H; Tong, X; Wang, S; Wu, Y; Xie, S; Yang, C | 1 |
| Abou Dalle, I; Al Chami, F; Bazarbachi, A; Charafeddine, M; El Cheikh, J; El Darsa, H; El Sayed, R; Ibrahim, A; Kort, J | 1 |
| Beeker, A; Berenschot, HW; Bilgin, YM; Böhmer, LH; Brouwer, RE; Chiţu, D; de Jong, D; Doorduijn, JK; Herbers, AHE; Hijmering, N; Hoogendoorn, M; Kersten, MJ; Koene, HR; Lam, KH; Lugtenburg, PJ; Schouten, HC; van der Burg-de Graauw, NC; van Imhoff, GW; Zijlstra, JM | 1 |
| Baldolli, A; Chuffart, M; Geffray, L; Reman, O; Verneuil, L | 1 |
| Chen, L; Du, J; Li, M; Li, Y; Mi, R; Wei, X; Yin, Q | 1 |
| Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P | 1 |
| Yamamoto, K | 1 |
| Berger, F; Brière, J; Canioni, D; Casasnovas, O; Coiffier, B; Copie-Bergman, C; Copin, MC; Fabiani, B; Fermé, C; Gaulard, P; Haioun, C; Jais, JP; Jardin, F; Leroy, K; Molina, TJ; Morschauser, F; Mounier, N; Petrella, T; Recher, C; Salles, G; Thieblemont, C; Tilly, H | 1 |
| Feng, G; Huang, XL; Wan, H; Wang, F; Wang, XJ | 1 |
| Advani, R; Constine, LS; Dabaja, BS; Dhakal, S; Flowers, CR; Ha, CS; Hodgson, DC; Hoppe, BS; Mendenhall, NP; Metzger, ML; Plastaras, JP; Roberts, KB; Shapiro, R; Smith, SM; Terezakis, SA; Winkfield, KM; Younes, A | 1 |
| Coiffier, B; Emile, JF; Fermé, C; Gabarre, J; Gisselbrecht, C; Haioun, C; Herbrecht, R; Morchhauser, F; Mounier, N; Ranta, D; Récher, C; Tilly, H | 1 |
| Aono, M; Matsuo, K; Shimada, H; Yago, K; Yanagita, S | 1 |
| Bosly, A; Brière, J; Coiffier, B; Gisselbrecht, C; Molina, T; Morel, P; Mounier, N; Munck, JN; Quesnel, B; Ranta, D; Reyes, F; Thyss, A; Tilly, H | 1 |
| Bardet, S; Berriolo-Riedinger, A; Bologna, S; Brière, J; Casasnovas, RO; Coiffier, B; Haioun, C; Jais, JP; Julian, A; Meignan, M; Morschhauser, F; Thieblemont, C; Vera, P | 1 |
| Anglaret, B; Belhadj, K; Brechignac, S; Casasnovas, O; Ferme, C; Feugier, P; Fitoussi, O; Gabarre, J; Ghesquieres, H; Gisselbrecht, C; Haioun, C; Herbrecht, R; Janvier, M; Morschhauser, F; Mounier, N; Parrens, M; Salles, G; Tilly, H; Van Den Neste, E; Ysebaert, L | 1 |
| Batchelor, TT; Egerer, G; Engert, A; Herrlinger, U; Kowoll, A; Lamprecht, M; Linnebank, M; Patrij, K; Pels, H; Reiser, M; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Vogt-Schaden, M; Wätzel, L | 1 |
| Vose, JM | 1 |
| Bologna, S; Bonnet, C; Bosly, A; Canioni, D; Casasnovas, O; Coiffier, B; Corront, B; Fermé, C; Fruchart, C; Gabarre, J; Ghesquières, H; Haioun, C; Jais, JP; Janvier, M; Jardin, F; Laurent, G; Molina, TJ; Morschhauser, F; Récher, C; Salles, G; Thiéblemont, C; Tilly, H | 1 |
| Habermann, TM | 1 |
| Bastit-Barrau, D; Bohbot, A; Bologna, S; Bourin, P; Fermé, C; Fitoussi, O; Fornecker, L; Haioun, C; Hequet, O; Isebaert, L; Lapierre, V; Lefrère, F; Mathieu-Nafissi, S; Micléa, JM; Mounier, N; Salles, G; Tilly, H | 1 |
| Anglaret, B; Bologna, S; Bonnet, C; Bordessoule, D; Brière, J; Casasnovas, O; Christian, B; Coiffier, B; Connerotte, T; Delarue, R; Fabiani, B; Fermé, C; Fruchart, C; Haioun, C; Ketterer, N; Morschhauser, F; Récher, C; Soussain, C; Thieblemont, C; Tilly, H | 1 |
| Coiffier, B; Reyes, F | 1 |
| Berneman, Z; Bosly, A; Bron, D; Dauwe, M; De Bock, R; Ferrant, A; Kaufman, L; Van Hoof, A; Verhoef, G | 1 |
| Brière, J; Copin, MC; Ferme, C; Gaulard, P; Gisselbrecht, C; Haioun, C; Hermine, O; Lederlin, P; Morel, P; Mounier, N; Salles, G; Theate, I; Tilly, H | 1 |
| Bastion, Y; Baumelou, E; Bouabdallah, K; Delannoy, A; Dupriez, B; Haioun, C; Herbrecht, R; Morel, P; Nouvel, C; Tilly, H | 1 |
| Alatriste, S; Avilés, A; Delgado, S; Díaz-Maqueo, JC; Nambo, MJ | 1 |
| Aoki, T; Hayashi, K; Imamura, M; Maetani, S; Nakayama, T; Onodera, H | 1 |
| Briere, J; d'Agay, MF; Diebold, J; Fillet, G; Gaulard, P; Haioun, C; Hermine, O; Lavignac, C; Lepage, E; Marolleau, JP; Reyas, F; Salles, G | 1 |
| Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O | 1 |
| Beaujean, F; Belhadj, K; Gaulard, PH; Gisselbrecht, CH; Haioun, C; Lepage, E; Marolleau, JP; Morel, P; Mounier, N; Quesnel, B; Reyes, F; Rieux, C; Simon, D | 1 |
| Charlotte, F; Godeau, P; Leblond, V; Piette, JC; Sbaï, A; Wechsler, B | 1 |
| Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
5 review(s) available for vindesine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
[Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Induction Chemotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rare Diseases; Rituximab; Skin Neoplasms; Vascular Neoplasms; Vindesine | 2013 |
[Standard of care and new drugs for diffuse large B-cell lymphoma].
Topics: Adenine; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Discovery; Epigenesis, Genetic; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Mice; Molecular Targeted Therapy; Piperidines; Prednisolone; Prednisone; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Rituximab; Thalidomide; Vincristine; Vindesine | 2014 |
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Prednisone; Radiotherapy; Rituximab; Vincristine; Vindesine | 2015 |
New developments in the management of diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Secondary Prevention; Stem Cell Transplantation; Thalidomide; Vincristine; Vindesine | 2012 |
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine | 2005 |
14 trial(s) available for vindesine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Rituximab-PECC induction followed by
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Survival Rate; Vindesine | 2019 |
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine | 2014 |
Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lympho
Topics: Adult; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemokine CCL2; Cyclophosphamide; Disease-Free Survival; DNA-Binding Proteins; Doxorubicin; Female; Humans; Immunohistochemistry; Immunotherapy; Interferon Regulatory Factors; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neprilysin; Prednisolone; Prednisone; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Treatment Outcome; Vincristine; Vindesine | 2014 |
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vindesine; Young Adult | 2009 |
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vindesine; Young Adult | 2010 |
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Vindesine | 2011 |
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vindesine; Young Adult | 2011 |
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Risk Assessment; Rituximab; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine; Vindesine; Young Adult | 2011 |
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vindesine | 2013 |
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Genes, bcl-2; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vindesine | 2008 |
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Creatinine; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney; Kidney Neoplasms; L-Lactate Dehydrogenase; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vindesine | 1994 |
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Vincristine; Vindesine | 1994 |
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Risk; Vindesine | 1996 |
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1998 |
13 other study(ies) available for vindesine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagic Cell Death; Beclin-1; Biopsy; Cell Line, Tumor; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Genetic Engineering; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Middle Aged; Oncolytic Virotherapy; Oncolytic Viruses; Prednisone; Rituximab; Tumor Escape; Vaccinia virus; Vincristine; Vindesine; Xenograft Model Antitumor Assays | 2021 |
Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Retrospective Studies; Vincristine; Vindesine; Young Adult | 2021 |
Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult | 2014 |
[Clinical Efficacy of Bleomycin, Cyclophosphamide, Vindesine, Ara-C and Dexamethasone for Treatment of Patients with Relapsed Refractory Diffuse Large B Cell Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Recurrence; Treatment Outcome; Vincristine; Vindesine | 2015 |
[Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Renal Insufficiency; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vascular Neoplasms; Vindesine | 2009 |
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Vindesine | 2011 |
Intensified chemotherapy for diffuse large B-cell lymphomas.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Rituximab; Vindesine | 2011 |
Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Rituximab; Vindesine; Young Adult | 2013 |
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Patient Selection; Prednisone; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 2008 |
[A case of a huge malignant lymphoma in the lesser omentum showing a long-term survival after combined treatment of surgery and VEP-THP chemotherapy].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Omentum; Peritoneal Neoplasms; Remission Induction; Vindesine | 1994 |
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Palliative Care; Pilot Projects; Prednisone; Prognosis; Risk Factors; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vindesine | 2001 |
[Multinodular hepatopathy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Sex Factors; Time Factors; Ultrasonography; Vindesine | 2002 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |